When you suffer from chronic pain, there are several different ways to treat it. Depending on where the pain originates, you may have undergone an injury or illness that caused chronic pain. Your condition may be an ongoing cause of pain, such as arthritis or cancer, but in many cases, there is no clear cause for chronic ache. Your doctor can perform a series of tests to determine what’s causing the pain, and he or she will recommend a treatment plan that addresses the underlying cause.
Many diseases and injuries can cause chronic pain. Injuries and surgeries can leave the body with changes that remain long after the injury has healed. The brain interprets these signals as pain. When the pain is severe, nerves can become hypersensitive, which leads to a vicious cycle of depression, anxiety, and difficulty sleeping. While you may be able to get rid of some of your pain through therapy, you may also be in need of other types of treatment.
The global chronic pain market is estimated to be valued at US$ 64,068 Mn in 2021 and is expected to exhibit a CAGR of 6.9% over the forecast period (2022-2028).
Request Here For The Sample Copy Of The Chronic Pain Report 2022 @
https://www.coherentmarketinsights.com/insight/request-sample/4767
Recent Developments
Major players operating in the global chronic pain market are focused on adopting various strategies to enhance their market share. For example, Nektar Therapeutics, in May 2019, established Inheris Biopharma, Inc., a CNS-focused company.
Market Drivers
Approval and launch of new products is expected to propel growth of the global chronic pain market over the forecast period. For instance, U.S. Food and Drug Administration in April 2018, accepted to review a Biologics License Application for tanezumab 2.5 mg administered subcutaneously from Pfizer Inc. and Eli Lilly and Company, for the treatment of chronic pain due to moderate-to-severe osteoarthritis.
Moreover, high prevalence of osteoarthritis is also expected to propel growth of the global chronic pain market over the forecast period. For instance, according to the study ‘Prevalence of Osteoarthritis in Russia: Regional Aspects of Trends in Statistical Parameters During 2011–2016’, published in 2018, in the journal Rheumatology Science and Practice, the prevalence of osteoarthritis in Russia increased from 32.2 per 1,000 population in 2011 to 35.7 in 2016. The highest prevalence of osteoarthritis was observed among the retirement-aged population averaging 33.2% of the number of registered patients per the total population in this age group.
Market Opportunities
R&D of new products is expected to offer lucrative growth opportunities for players in the global chronic pain market. For instance, Tonix Pharmaceuticals Holding Corp., in June 2021, presented positive results from its Phase 3 clinical study, RELIEF, of TNX-102 SL for the management of fibromyalgia.
Market Trends
North America is expected to witness significant growth in the global chronic pain market, owing to high prevalence of chronic pain in the region. For instance, around 50 million adults in the U.S suffer from chronic or severe pain, according to a 2012 study of the National Institutes of Health’s National Center for Complementary and Integrative Health.
Market Segmentation:
By Drug:
- Opioids
- Non-steroidal anti- inflammatory drugs (NSAIDS)
- Anticonvulsants
- Antidepressants
- Others
By Indication:
- Neuropathic Pain
- Arthritis Pain
- Chronic Back Pain
- Cancer Pain
- Migraine
- Fibromyalgia
- Others
By Application:
- Musculoskeletal
- Neuropathy
- Oncology
- Others
Regional Analysis:
» North America: United States, Canada, and Mexico
» South & Central America: Argentina, Chile, Brazil and Others
» Middle East & Africa: Saudi Arabia, UAE, Israel, Turkey, Egypt, South Africa & Rest of MEA.
» Europe: UK, France, Italy, Germany, Spain, BeNeLux, Russia, NORDIC Nations and Rest of Europe.
» Asia-Pacific: India, China, Japan, South Korea, Indonesia, Thailand, Singapore, Australia and Rest of APAC.
Get PDF Brochure Discover more about report analysis with figures and data tables, along with the table of contents:
https://www.coherentmarketinsights.com/insight/request-pdf/4767
Market Restraints
Product recalls and availability of digital alternative products is expected to hinder growth of the global chronic pain market. For instance, Merck & Co., in September 2004, recalled arthritis and pain drug Vioxx (rofecoxib) due to an increased risk for heart attacks and strokes.
The U.S. Food and Drug Administration, in August 2021, granted Breakthrough Device Designation to Swing Therapeutics’ digital therapeutics for the management of fibromyalgia.
Key Players
Major players operating in the global chronic pain market include, Abbott Laboratories, AstraZeneca plc., Bristol-Myers Squibb Company, Becton, Dickinson and Company, Eli Lilly and Company, GlaxoSmithKline plc., Johnson & Johnson, Novartis AG, Pfizer Inc., and Sanofi S.A.
FAQ’S:
• In 2028, what will be the market size and growth rate be?
• What are the main drivers of the global Chronic Pain Market?
• What are the major market trends influencing the worldwide growth of Chronic Pain Market?
• What are the obstacles to market expansion?
• Who are the major suppliers of Chronic Pain Market throughout the world?
• What market opportunities and dangers do suppliers encounter in the worldwide Chronic Pain Market?
• What are the primary findings of the worldwide Chronic Pain Market five forces analysis?
𝐑𝐞𝐚𝐬𝐨𝐧𝐬 𝐭𝐨 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭
✔ Current and future of global Chronic Pain market outlook in the developed and emerging markets
✔ The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
✔ Regions/countries that are expected to witness the fastest growth rates during the forecast period
✔ The latest developments, market shares, and strategies that are employed by the major market players
Buy This Complete Business Report @
https://www.coherentmarketinsights.com/insight/buy-now/4767
Table Of Content:
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Overview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Drugs
- Market Snippet, By Indication
- Market Snippet, By Application
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Key Development
- Market Trends
- Technology Landscape
- New Device/Product Launches
- PEST Analysis
- Porter’s Five Forces Analysis
- Market Dynamics
- Global Chronic Pain Market – Impact of Coronavirus (Covid-19) Pandemic
- Impact on Demand
- Impact on Healthcare
- Global Chronic Pain Market, By Drugs, 2017-2028 (US$ Million)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Segment Trends
- Opioids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Non-steroidal anti-inflammatory drugs (NSAIDS)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Anticonvulsants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Antidepressants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Introduction
- Global Chronic Pain Market, By Indication, 2017-2028 (US$ Million)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Segment Trends
- Neuropathic Pain
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Arthritis Pain
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Chronic Back Pain
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Cancer Pain
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Migraine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Fibromyalgia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Introduction
- Global Chronic Pain Market, By Application, 2017-2028 (US$ Million)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Segment Trends
- Musculoskeletal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Neuropathy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Introduction
- Global Chronic Pain Market, By Distribution Channel, 2017-2028 (US$ Million)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Introduction
- Global Chronic Pain Market, By Region, 2017 – 2028 (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, For Regions, 2018 – 2028
- Regional Trends
- North America
- Market Size and Forecast, By Drug, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Indication, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Application, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Country, 2017 – 2028 (US$ Mn)
- U.S.
- Canada
- Latin America
- Market Size and Forecast, By Drug, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Indication, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Application, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Country, 2017 – 2028 (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size and Forecast, By Drug, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Indication, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Application, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Country, 2017 – 2028 (US$ Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Drug, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Indication, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Application, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Country, 2017 – 2028 (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Market Size and Forecast, By Drug, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Indication, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Application, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Country, 2017 – 2028 (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Drug, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Indication, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Application, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Country, 2017 – 2028 (US$ Mn)
- South Africa
- Central Africa
- North Africa
- Introduction
- Competitive Landscape
- Company Profiles
- Eli Lilly and Company
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- GlaxoSmithKline plc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Pfizer Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Abbott Laboratories
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Novartis AG
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Johnson & Johnson
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- AstraZeneca plc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Bristol-Myers Squibb Company
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Becton, Dickinson and Company
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Sanofi S.A.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Eli Lilly and Company
- Analyst Views
- Company Profiles
- Section
- References
- Research Methodology
- About us and Sales Contact
About Coherent Market Insights
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact Us:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837